Maider Medical Industry Equipment Co. Ltd. (SHA:688310)
China
· Delayed Price · Currency is CNY 17.30
+0.36 (2.13%)
Mar 10, 2026, 3:00 PM CST
SHA:688310 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 447.42 | 271.28 | 476.26 | 380.08 | 313.06 | Upgrade
|
| Other Revenue | - | 3.58 | 3.96 | 3.41 | 2.46 | Upgrade
|
| Revenue | 447.42 | 274.85 | 480.22 | 383.49 | 315.53 | Upgrade
|
| Revenue Growth (YoY) | 62.79% | -42.77% | 25.22% | 21.54% | 19.89% | Upgrade
|
| Cost of Revenue | - | 156.93 | 235.72 | 191.43 | 159.32 | Upgrade
|
| Gross Profit | 447.42 | 117.92 | 244.5 | 192.06 | 156.21 | Upgrade
|
| Selling, General & Admin | - | 120.26 | 118.01 | 93.77 | 64.56 | Upgrade
|
| Research & Development | - | 40.41 | 33.18 | 36.66 | 38.46 | Upgrade
|
| Other Operating Expenses | 387.72 | -9.6 | -16.01 | -9.02 | -5.89 | Upgrade
|
| Operating Expenses | 387.72 | 147.4 | 138.76 | 125.65 | 99.2 | Upgrade
|
| Operating Income | 59.7 | -29.48 | 105.74 | 66.41 | 57.01 | Upgrade
|
| Interest Expense | - | -0.06 | -0.08 | -0.1 | -0.12 | Upgrade
|
| Interest & Investment Income | - | 3.09 | 7.26 | 13.61 | 7.33 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.33 | 0.53 | 0.68 | -0.71 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.52 | -0.12 | -0.08 | -0.06 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | 61.22 | -26.9 | 113.37 | 80.54 | 63.45 | Upgrade
|
| Impairment of Goodwill | - | -10.42 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 2.24 | 2.66 | 0.15 | 0.03 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.3 | -0.03 | 0.21 | -0.06 | Upgrade
|
| Other Unusual Items | - | 5.55 | 11.43 | 6.33 | 7.05 | Upgrade
|
| Pretax Income | 61.22 | -29.23 | 127.43 | 87.22 | 70.47 | Upgrade
|
| Income Tax Expense | -4.04 | 0.78 | 17.82 | 10.2 | 6.5 | Upgrade
|
| Earnings From Continuing Operations | 65.26 | -30.01 | 109.61 | 77.02 | 63.97 | Upgrade
|
| Minority Interest in Earnings | - | 10.03 | -9.78 | -10 | 0.51 | Upgrade
|
| Net Income | 65.26 | -19.98 | 99.83 | 67.02 | 64.48 | Upgrade
|
| Net Income to Common | 65.26 | -19.98 | 99.83 | 67.02 | 64.48 | Upgrade
|
| Net Income Growth | - | - | 48.94% | 3.95% | 9.15% | Upgrade
|
| Shares Outstanding (Basic) | 163 | 167 | 164 | 165 | 164 | Upgrade
|
| Shares Outstanding (Diluted) | 163 | 167 | 164 | 165 | 164 | Upgrade
|
| Shares Change (YoY) | -2.02% | 1.75% | -0.60% | 0.32% | 0.63% | Upgrade
|
| EPS (Basic) | 0.40 | -0.12 | 0.61 | 0.41 | 0.39 | Upgrade
|
| EPS (Diluted) | 0.40 | -0.12 | 0.61 | 0.41 | 0.39 | Upgrade
|
| EPS Growth | - | - | 49.84% | 3.61% | 8.48% | Upgrade
|
| Free Cash Flow | - | -29.46 | 38.7 | -38.36 | -27.77 | Upgrade
|
| Free Cash Flow Per Share | - | -0.18 | 0.24 | -0.23 | -0.17 | Upgrade
|
| Dividend Per Share | - | - | 0.357 | 0.245 | 0.194 | Upgrade
|
| Dividend Growth | - | - | 45.81% | 26.30% | -23.99% | Upgrade
|
| Gross Margin | 100.00% | 42.90% | 50.91% | 50.08% | 49.51% | Upgrade
|
| Operating Margin | 13.34% | -10.73% | 22.02% | 17.32% | 18.07% | Upgrade
|
| Profit Margin | 14.59% | -7.27% | 20.79% | 17.48% | 20.43% | Upgrade
|
| Free Cash Flow Margin | - | -10.72% | 8.06% | -10.00% | -8.80% | Upgrade
|
| EBITDA | 90.5 | 1.32 | 134.17 | 81.44 | 63.48 | Upgrade
|
| EBITDA Margin | 20.23% | 0.48% | 27.94% | 21.24% | 20.12% | Upgrade
|
| D&A For EBITDA | 30.8 | 30.8 | 28.43 | 15.03 | 6.47 | Upgrade
|
| EBIT | 59.7 | -29.48 | 105.74 | 66.41 | 57.01 | Upgrade
|
| EBIT Margin | 13.34% | -10.73% | 22.02% | 17.32% | 18.07% | Upgrade
|
| Effective Tax Rate | - | - | 13.99% | 11.69% | 9.23% | Upgrade
|
| Revenue as Reported | - | 274.85 | 480.22 | 383.49 | 315.53 | Upgrade
|
| Advertising Expenses | - | 3.87 | 5.34 | 0.91 | 0.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.